TECVAYLI

all catalysts(0)

nothing on the calendar yet

News(6)

• Legend Biotech CEO abruptly steps down without permanent replacement
  In a sudden leadership shift, Legend Biotech announced that its CEO, Ying Huang, Ph.D., resigned on Friday, with no permanent replacement yet named.
  fiercebiotech · 18d ago
• Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myeloma
  Novo is seeking an injunction that would halt allegedly “misleading” obesity drug ads. Elsewhere, the FDA began reviewing a highly anticipated medicine and a veteran investor landed at an AI startup.
  biopharma_dive · 21d ago
• ‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D wins
  A string of recent wins on the frontiers of novel drug development could mean that a homegrown innovation industry is within reach.
  fiercebiotech · 29d ago
• On second try, Acadia drug gets nod from European regulators
  The influential CHMP committee also threw its support behind more than a dozen other medicines while recommending the marketing authorization for Tavneos be revoked.
  biopharma_dive · 1mo ago
• CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine
  A Series D round led by Venrock will support an ongoing Phase 2 study, and planned Phase 3 trial, of an oral drug the biotech sees as a differentiated option for patients with persistent disease.
  biopharma_dive · 3mo ago
• FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
  Through two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it’s accrued. Elsewhere, Lilly inked a gene editing deal and Pfizer reported success for a multipl…
  biopharma_dive · 3mo ago